InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SVM Insider Trading

Insider Ownership Percentage: 34.74%
Insider Buying (Last 12 Months): A$369,000.00
Insider Selling (Last 12 Months): A$0.00

Sovereign Metals Insider Trading History Chart

This chart shows the insider buying and selling history at Sovereign Metals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sovereign Metals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for SVM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Sovereign Metals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/29/2023Julian StephensInsiderBuy900,000A$0.41A$369,000.00
11/23/2022Benjamin StoikovichInsiderIssued360,000A$0.50A$180,000.00
8/11/2022Benjamin StoikovichInsiderBuy572A$0.25A$144.72
6/23/2022Benjamin StoikovichInsiderExercise1,500,000A$0.47A$705,000.00
12/23/2021Benjamin StoikovichInsiderBuy360,000A$0.57A$205,200.00
11/25/2021Mark PearceInsiderIssued750,000A$0.65A$487,500.00
6/18/2021Julian StephensInsiderBuy2,000,000A$0.10A$200,000.00
6/11/2021Benjamin StoikovichInsiderExercise1,500,000A$0.10A$150,000.00
12/23/2020Julian StephensInsiderIssued3,000,000A$0.36A$1,065,000.00
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Sovereign Metals (ASX:SVM)

10.93% of Sovereign Metals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sovereign Metals Limited, together with its subsidiaries, engages in the exploration, development, and appraisal of mineral resource projects in Malawi. Its flagship project is the Kasiya rutile deposit in Malawi. Sovereign Metals Limited was incorporated in 2006 and is headquartered in Perth, Australia.
Read More on Sovereign Metals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

210,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

12.77%

Beta

1.11

Who are the company insiders with the largest holdings of Sovereign Metals?

Sovereign Metals' top insider shareholders include:
  1. Benjamin Stoikovich (Insider)
  2. Julian Stephens (Insider)
Learn More about top insider investors at Sovereign Metals.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.